Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Effectively tracking personal expenses is key to successful budgeting. Discover various methods to simplify your financial management.
20,024 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A hotter-than-expected inflation reading paired with robust payroll gains left the newly named Fed chair navigating a...
Two pharma giants sit at the center of the booming weight-loss drug market. This piece breaks down which could offer ...
As the power transition accelerates, two giants—American Electric Power and GE Vernova—offer very different routes fo...
As AI fuels data growth, Silicon Motion Technology stands out in the memory controller niche. This article breaks dow...
Two tech giants sit at the edge of a historic crown. This piece breaks down what would drive Apple about away from Nv...
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
This analysis dives into the early 2026 earnings picture for J.Jill, unpacking revenue drivers, margin dynamics, and ...
As AI models scale, memory bandwidth becomes the bottleneck. This article digs into Nvidia's role in HBM4, the chatte...
Agentic AI could automate payments and settlements in crypto, but it needs solid blockchain rails. This piece breaks ...
Roku stock has slipped about 17% year-to-date, even as the company shows improving profitability and optimism for gro...
Stepan (SCL) investors are focused on 2025 earnings drivers, margins, and cash flow. This guide breaks down the key c...